Skip to main content
Premium Trial:

Request an Annual Quote

Ambry Genetics Certified to Offer Roche NimbleGen CGH, ChIP-chip, Methylation, and Expression Arrays


Ambry Genetics has become a certified service provider for Roche NimbleGen comparative genomic hybridization, chromatin immunoprecipitation-on-chip, DNA methylation, and gene expression arrays, Roche said this week.

Aliso Viejo, Calif.-based Ambry can now process customer samples for copy number variation, DNA-methylation analysis, gene-expression analysis, and DNA-protein interactions and chromatin structure. The company had previously been certified to offer Nimblegen sequence capture services (BAN 3/24/2011).

Ambry Genetics is now able to offer all Roche NimbleGen applications, the first of Roche NimbleGen's growing list of service providers to achieve such certification, Roche added.

Roche NimbleGen has certified a number of service providers in recent years. Most recently, it certified Berlin-based Atlas Biolabs to offer sequence capture services on arrays and in solution to European customers. Altogether, nearly a dozen companies and institutions in North America, South America, Europe, and Asia now offer different applications on Roche NimbleGen's arrays.

Ambry Genetics is Roche NimbleGen's sole service provider in North America.

The Scan

Driving Malaria-Carrying Mosquitoes Down

Researchers from the UK and Italy have tested a gene drive for mosquitoes to limit the spread of malaria, NPR reports.

Office Space to Lab Space

The New York Times writes that some empty office spaces are transforming into lab spaces.

Prion Pause to Investigate

Science reports that a moratorium on prion research has been imposed at French public research institutions.

Genome Research Papers on Gut Microbe Antibiotic Response, Single-Cell RNA-Seq Clues to Metabolism, More

In Genome Research this week: gut microbial response to antibiotic treatment, approach to gauge metabolic features from single-cell RNA sequencing, and more.